Zarzio (filgrastim) has been launched for the treatment of neutropenia, associated with chemotherapy or HIV infection.

Zarzio therapy should only be given in collaboration with an oncology centre which has experience in granulocyte-colony stimulating factor  (G-CSF) treatment and haemotology and has the necessary diagnostic facilities.

View Zarzio drug record

Further information: Sandoz

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more